Fischer Medical Ventures Ltd. - Research Center
524743 FISCHER Group (B) BSE data
Results
Statement
More
| Mar ' 25 |
Mar ' 24 |
Mar ' 23 |
Mar ' 22 |
Mar ' 21 |
Equity share capital
| 63.80 |
53.50 |
0.17 |
0.17 |
0.17 |
Share application money
Preference share capital
Reserves & surplus
| 241.66 |
25.31 |
-0.44 |
-0.40 |
-0.17 |
Secured loans
Unsecured loans
Total
| 335.69 |
79.68 |
0.31 |
0.16 |
0.24 |
Gross block
Less : revaluation reserve
Less : accumulated depreciation
Net block
Capital work-in-progress
Investments
Current assets, loans & advances
| 63.47 |
50.54 |
0.35 |
0.19 |
0.25 |
Less : current liabilities & provisions
| 22.82 |
12.15 |
0.05 |
0.03 |
0.02 |
Total net current assets
| 40.65 |
38.39 |
0.31 |
0.16 |
0.24 |
Miscellaneous expenses not written
Total
| 335.69 |
79.68 |
0.31 |
0.16 |
0.24 |
Book value of unquoted investments
Market value of quoted investments
Contingent liabilities
Number of equity sharesoutstanding (Lacs)
| 638.02 |
535.00 |
1.72 |
1.72 |
1.72 |